Works by Willemin, Marie‐Emilie

Results: 9

Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term.

Published in:

Pharmaceutics, 2025, v. 17, n. 5, p. 560, doi. 10.3390/pharmaceutics17050560

By:

Stader, Felix;
Sharma, Pradeep;
Huang, Weize;
Choules, Mary P.;
Willemin, Marie-Emilie;
Zhang, Xinwen;
Yau, Estelle;
Derbalah, Abdallah;
Zyla, Adriana;
Liu, Cong;
Sepp, Armin

Publication type:

Article

Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model

Published in:

Targeted Oncology, 2024, v. 19, n. 6, p. 965, doi. 10.1007/s11523-024-01093-6

By:

Willemin, Marie-Emilie;
Gong, Jue;
Hilder, Brandi W.;
Masterson, Tara;
Tolbert, Jaszianne;
Renaud, Thomas;
Heuck, Christoph;
Kane, Colleen;
De Zwart, Loeckie;
Girgis, Suzette;
Ma, Xuewen;
Ouellet, Daniele

Publication type:

Article

Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1117, doi. 10.1002/psp4.13144

By:

Willemin, Marie‐Emilie;
Wang Lin, Shun Xin;
De Zwart, Loeckie;
Wu, Liviawati S.;
Miao, Xin;
Verona, Raluca;
Banerjee, Arnob;
Liu, Baolian;
Kobos, Rachel;
Qi, Ming;
Ouellet, Daniele;
Goldberg, Jenna D.;
Girgis, Suzette

Publication type:

Article

Utilization of OATP1B Biomarker Coproporphyrin‐I to Guide Drug–Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 6, p. 1170, doi. 10.1002/cpt.3062

By:

Kikuchi, Ryota;
Chothe, Paresh P.;
Chu, Xiaoyan;
Huth, Felix;
Ishida, Kazuya;
Ishiguro, Naoki;
Jiang, Rongrong;
Shen, Hong;
Stahl, Simone H.;
Varma, Manthena V.S.;
Willemin, Marie‐Emilie;
Morse, Bridget L.

Publication type:

Article

Development of 4‐Pyridoxic Acid PBPK Model to Support Biomarker‐Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 6, p. 1243, doi. 10.1002/cpt.3029

By:

Tan, Shawn Pei Feng;
Willemin, Marie‐Emilie;
Snoeys, Jan;
Shen, Hong;
Rostami‐Hodjegan, Amin;
Scotcher, Daniel;
Galetin, Aleksandra

Publication type:

Article

Thiocyanate: a review and evaluation of the kinetics and the modes of action for thyroid hormone perturbations.

Published in:

Critical Reviews in Toxicology, 2017, v. 47, n. 7, p. 537, doi. 10.1080/10408444.2017.1281590

By:

Willemin, Marie-Emilie;
Lumen, Annie

Publication type:

Article

Prediction of Drug-Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model.

Published in:

2022

By:

Willemin, Marie-Emilie;
Zannikos, Peter;
Mannens, Geert;
de Zwart, Loeckie;
Snoeys, Jan

Publication type:

journal article

Correction to: Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions.

Published in:

2022

By:

Willemin, Marie-Emilie;
Van Der Made, Thomas K.;
Pijpers, Ils;
Dillen, Lieve;
Kunze, Annett;
Jonkers, Sophie;
Steemans, Kathleen;
Tuytelaars, An;
Jacobs, Frank;
Monshouwer, Mario;
Scotcher, Daniel;
Rostami-Hodjegan, Amin;
Galetin, Aleksandra;
Snoeys, Jan

Publication type:

Correction Notice

Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions.

Published in:

Clinical Pharmacokinetics, 2021, v. 60, n. 9, p. 1187, doi. 10.1007/s40262-021-01004-2

By:

Willemin, Marie-Emilie;
Van Der Made, Thomas K.;
Pijpers, Ils;
Dillen, Lieve;
Kunze, Annett;
Jonkers, Sophie;
Steemans, Kathleen;
Tuytelaars, An;
Jacobs, Frank;
Monshouwer, Mario;
Scotcher, Daniel;
Rostami-Hodjegan, Amin;
Galetin, Aleksandra;
Snoeys, Jan

Publication type:

Article